Forgiving lens

Forgiving lens
Ophtec BV has received a CE mark for a new aspheric presbyopia correcting intraocular lens (IOL), Precizon Presbyopic, with a patent-pending continuous transitional focus (CTF) optical design. “The new CTF optic seems to offer a safer surgical approach than traditional multifocal technologies available on the market, and addresses the fact that nature is not an optical bench and IOL seating is important for good performance,” said a company spokesman. “The technology offers a full range of vision and, due to the CTF’s transitional zones, a smooth, continuous transition from near vision to infinity is achieved. Consequently, CTF ensures a more 'forgiving' lens that enables surgeons to treat a wider range of presbyopic patients with a higher degree of confidence,” he said. Precizon Presbyopic will be commercially launched in October during the XXXV Congress of the ESCRS in Lisbon, Portugal. The product will initially be available in the European Union and a few selected markets. www.ophtec.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...